Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
about
Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposureClinical review: sepsis and septic shock--the potential of gene arraysPretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.Exploring the boundaries of systemic inflammation*.Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trialComputational identification of transcriptional regulators in human endotoxemiaMultiscale model for the assessment of autonomic dysfunction in human endotoxemia.APOε4 is associated with enhanced in vivo innate immune responses in human subjectsIn vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes.Transcriptome kinetics of circulating neutrophils during human experimental endotoxemia.Scavenger receptor-A (CD204): a two-edged sword in health and diseaseRoles of SIRT1 in the acute and restorative phases following induction of inflammation.An agent-based model of cellular dynamics and circadian variability in human endotoxemia.Modeling endotoxin-induced systemic inflammation using an indirect response approach.Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.Cellular metabolic regulators: novel indicators of low-grade inflammation in humans.Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia.Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS.Endotoxemia in pediatric critical illness--a pilot study.Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled studyProteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes.Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial.Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemiaFrom therapy to experimental model: a hundred years of endotoxin administration to human subjects.Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans.Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation.Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandinsA critical review of human endotoxin administration as an experimental paradigm of depression.Understanding Physiology in the Continuum: Integration of Information from Multiple -Omics Levels.Temporal metabolic profiling of plasma during endotoxemia in humans.Modeling physiologic variability in human endotoxemia.Translational applications of evaluating physiologic variability in human endotoxemia.Lipopolysaccharide challenge: immunological effects and safety in humans.On heart rate variability and autonomic activity in homeostasis and in systemic inflammation.Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity.Ethylene, an early marker of systemic inflammation in humans.Pain perception in healthy volunteers: effect of repeated exposure to experimental systemic inflammation.Protein kinetics in human endotoxaemia and their temporal relation to metabolic, endocrine and proinflammatory cytokine responses.Predicting critical transitions in a model of systemic inflammation.
P2860
Q24607056-2BC346F1-4D50-4B39-8DD6-C862C996BFB9Q26864138-FA515B7F-F20E-4CFC-A937-5198A9450155Q33641150-A7E4ABE0-E257-4FFB-AF32-74D48E7D0CA4Q33767344-FCDAE589-3B0E-411F-ACC3-292B4B7A8110Q33796490-AE2D385D-2685-484A-9AC6-B66CE5EA271BQ33921020-772625AD-2A06-4602-ACEE-4C8FE2795ADFQ33924871-32DE9B89-C0F3-4AD5-909B-CCD5425EBD12Q34017080-EADF3B31-23C5-4147-92B8-30A5989AFEB9Q34091078-50CD15EC-DC1F-42AE-BA52-5E736E62AC5EQ34297093-B90198A3-0109-4D2F-91FF-EFBEDB95A0B7Q34313964-697D2813-EDEB-41B6-8847-7052EEF0E308Q34438754-3CE0B448-A50E-4DE7-B8A7-9B4B21DF7C43Q34576707-E4E51CA6-78D2-441E-866D-BC3C9AC65FDEQ34611156-A55122FF-7805-4F37-B8D7-A05AEB9D722BQ35110779-ED85CFCB-70BC-4BAD-AE3A-BC4945F03751Q35185112-D311A0A8-3A62-421C-BC67-75DAE1782CC9Q35233854-345FE357-145C-4632-839D-F4CF2F7007C5Q35247557-B3D44563-1875-467E-8182-D440FCAF764EQ35558313-DD30514D-DBCC-47D5-997E-B34A4B5520FFQ35782019-84F57DA7-F2AF-46E3-BFD7-08BF276CCB81Q35988805-3F44A866-53EF-48FD-ADDE-DF7B50366D54Q36132546-A0C2208B-CC6D-4BA5-A2C1-72021266C00AQ36909379-248C7898-D732-4DBD-8430-CEB08935C056Q36994694-F6FB185B-84BE-4322-93BD-D9853C4A572CQ37030301-B3EBB5ED-DBA0-4388-83D0-ABE2B51ECE5BQ37088166-D03F97D1-3BBD-42E9-BF7C-CA05AF6CB886Q37296981-96162B22-CFBC-4173-BA72-4950FEB51AA7Q37481759-D33697D4-5046-4824-9351-71AD2EB49DD6Q37668704-E64FAFAE-3CBC-44D2-A7FA-9DCCE8695122Q37674614-5F8FE0BE-E4DE-4774-B5E8-05FB286DBBE8Q38058812-CFA5F2F6-8B30-4761-AFF6-B83C81E4AC78Q38064340-B3FE7624-07BE-4BED-A0D2-AA53F8403DBBQ38345644-52445167-DE1A-4AD3-998A-90A2480B7E05Q39220198-AF16F4F6-6C52-42FB-95C9-687234C38997Q39428459-37C33E2D-0AC0-4146-AE53-50E616D5B98EQ39656925-7646E6DA-A616-45B8-8076-1C006EF0554CQ40112407-51B8BC26-2036-4583-8DEF-41F7D73339E6Q40565506-8B9860A7-745E-4B93-8BFD-A4F4C1E7083CQ41251858-D43395AD-3912-428D-A32D-840C0D6DB124Q41874778-4AC12A78-736A-4222-9B4F-981444C6DC37
P2860
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@ast
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@en
type
label
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@ast
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@en
prefLabel
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@ast
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@en
P1433
P1476
Human endotoxemia: a model for mechanistic insight and therapeutic targeting.
@en
P2093
Stephen F Lowry
P304
P356
10.1097/01.SHK.0000191340.23907.A1
P478
24 Suppl 1
P577
2005-12-01T00:00:00Z